• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆盐输出泵(BSEP)的生物合成与转运:BSEP突变的治疗意义

Biosynthesis and trafficking of the bile salt export pump, BSEP: therapeutic implications of BSEP mutations.

作者信息

Soroka Carol J, Boyer James L

机构信息

Yale University School of Medicine, Department of Internal Medicine, New Haven, CT 06520, United States.

出版信息

Mol Aspects Med. 2014 Jun;37:3-14. doi: 10.1016/j.mam.2013.05.001. Epub 2013 May 15.

DOI:10.1016/j.mam.2013.05.001
PMID:23685087
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3784619/
Abstract

The bile salt export pump (BSEP, ABCB11) is the primary transporter of bile acids from the hepatocyte to the biliary system. This rate-limiting step in bile formation is essential to the formation of bile salt dependent bile flow, the enterohepatic circulation of bile acids, and the digestion of dietary fats. Mutations in BSEP are associated with cholestatic diseases such as progressive familial intrahepatic cholestasis type 2 (PFIC2), benign recurrent intrahepatic cholestasis type 2 (BRIC2), drug-induced cholestasis, and intrahepatic cholestasis of pregnancy. Development of clinical therapies for these conditions necessitates a clear understanding of the cell biology of biosynthesis, trafficking, and transcriptional and translational regulation of BSEP. This chapter will focus on the molecular and cell biological aspects of this critical hepatic membrane transporter.

摘要

胆盐输出泵(BSEP,ABCB11)是胆汁酸从肝细胞转运至胆道系统的主要转运体。胆汁形成过程中的这一限速步骤对于依赖胆盐的胆汁流动、胆汁酸的肠肝循环以及膳食脂肪的消化至关重要。BSEP的突变与胆汁淤积性疾病相关,如2型进行性家族性肝内胆汁淤积症(PFIC2)、2型良性复发性肝内胆汁淤积症(BRIC2)、药物性胆汁淤积以及妊娠期肝内胆汁淤积症。针对这些病症开发临床治疗方法需要清楚了解BSEP生物合成、转运以及转录和翻译调控的细胞生物学机制。本章将聚焦于这一关键肝细胞膜转运体的分子和细胞生物学方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d433/3784619/06f305da0fe7/nihms-481143-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d433/3784619/0c49a58d9615/nihms-481143-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d433/3784619/90c3ab170963/nihms-481143-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d433/3784619/06f305da0fe7/nihms-481143-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d433/3784619/0c49a58d9615/nihms-481143-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d433/3784619/90c3ab170963/nihms-481143-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d433/3784619/06f305da0fe7/nihms-481143-f0003.jpg

相似文献

1
Biosynthesis and trafficking of the bile salt export pump, BSEP: therapeutic implications of BSEP mutations.胆盐输出泵(BSEP)的生物合成与转运:BSEP突变的治疗意义
Mol Aspects Med. 2014 Jun;37:3-14. doi: 10.1016/j.mam.2013.05.001. Epub 2013 May 15.
2
Levels of plasma membrane expression in progressive and benign mutations of the bile salt export pump (Bsep/Abcb11) correlate with severity of cholestatic diseases.胆汁盐输出泵(Bsep/Abcb11)的进行性和良性突变中的质膜表达水平与胆汁淤积性疾病的严重程度相关。
Am J Physiol Cell Physiol. 2007 Nov;293(5):C1709-16. doi: 10.1152/ajpcell.00327.2007. Epub 2007 Sep 13.
3
Bile salt export pump (BSEP/ABCB11): trafficking and sorting disturbances.胆汁盐输出泵(BSEP/ABCB11):转运和分拣障碍。
Curr Mol Pharmacol. 2013 Jul;6(2):95-103. doi: 10.2174/18744672113069990036.
4
The bile salt export pump: clinical and experimental aspects of genetic and acquired cholestatic liver disease.胆汁盐输出泵:遗传和获得性胆汁淤积性肝病的临床和实验方面。
Semin Liver Dis. 2010 May;30(2):125-33. doi: 10.1055/s-0030-1253222. Epub 2010 Apr 26.
5
Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.进行性家族性肝内胆汁淤积症患者的肝小管胆汁盐输出泵缺乏
Gastroenterology. 1999 Dec;117(6):1370-9. doi: 10.1016/s0016-5085(99)70287-8.
6
Impaired expression and function of the bile salt export pump due to three novel ABCB11 mutations in intrahepatic cholestasis.由于肝内胆汁淤积症中的三种新型ABCB11突变导致胆盐输出泵的表达和功能受损。
J Hepatol. 2005 Sep;43(3):536-43. doi: 10.1016/j.jhep.2005.05.020.
7
The Bile Salt Export Pump: Molecular Structure, Study Models and Small-Molecule Drugs for the Treatment of Inherited BSEP Deficiencies.胆盐输出泵:分子结构、研究模型及用于治疗遗传性BSEP缺陷的小分子药物
Int J Mol Sci. 2021 Jan 14;22(2):784. doi: 10.3390/ijms22020784.
8
The bile salt export pump: molecular properties, function and regulation.胆盐输出泵:分子特性、功能及调控
Pflugers Arch. 2004 Nov;449(2):123-31. doi: 10.1007/s00424-004-1311-4. Epub 2004 Jul 24.
9
Benign recurrent intrahepatic cholestasis associated with mutations of the bile salt export pump.与胆盐输出泵突变相关的良性复发性肝内胆汁淤积症
J Clin Gastroenterol. 2006 Feb;40(2):171-5. doi: 10.1097/01.mcg.0000196406.15110.60.
10
The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.牛磺胆酸钠共转运多肽(NTCP)和胆盐输出泵(BSEP)在胆汁形成的生理和病理生理中的作用。
Handb Exp Pharmacol. 2011(201):205-59. doi: 10.1007/978-3-642-14541-4_5.

引用本文的文献

1
Age-Independent Hypocholesterolemic Effects of Rice Protein via FXR-Mediated Stimulation of Cholesterol Elimination.大米蛋白通过FXR介导刺激胆固醇消除产生与年龄无关的降胆固醇作用。
Food Sci Nutr. 2025 Jul 28;13(8):e70687. doi: 10.1002/fsn3.70687. eCollection 2025 Aug.
2
Engineering a Human-Sized Common Bile Duct Prototype with Regenerative Potential: In Vitro Evaluation of Mechanics, Function, Degradation, and Immune Modulation.构建具有再生潜力的人体尺寸胆总管原型:力学、功能、降解及免疫调节的体外评估
Adv Healthc Mater. 2025 Aug;14(21):e2501660. doi: 10.1002/adhm.202501660. Epub 2025 Jun 16.
3
A structural and mechanistic model for BSEP dysfunction in PFIC2 cholestatic disease.

本文引用的文献

1
Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma.胆汁盐输出泵在肝癌患者中出现法尼醇 X 受体同工型表达改变而失调。
Hepatology. 2013 Apr;57(4):1530-41. doi: 10.1002/hep.26187. Epub 2013 Feb 15.
2
Adult sea lamprey tolerates biliary atresia by altering bile salt composition and renal excretion.成体海鳗通过改变胆汁盐组成和肾脏排泄来耐受胆道闭锁。
Hepatology. 2013 Jun;57(6):2418-26. doi: 10.1002/hep.26161.
3
Progressive familial intrahepatic cholestasis.进行性家族性肝内胆汁淤积症。
PFIC2胆汁淤积性疾病中BSEP功能障碍的结构和机制模型。
Commun Biol. 2025 Apr 7;8(1):531. doi: 10.1038/s42003-025-07908-0.
4
Evaluation of the significance of single nucleotide polymorphisms of the gene as biomarkers of hepatological complications in Epstein-Barr virus infection in children.评估该基因单核苷酸多态性作为儿童爱泼斯坦-巴尔病毒感染中肝脏并发症生物标志物的意义。
Clin Exp Hepatol. 2024 Mar;10(2):104-110. doi: 10.5114/ceh.2024.140450. Epub 2024 Jun 11.
5
Interleukin 1 β suppresses bile acid-induced BSEP expression via a CXCR2-dependent feedback mechanism.白细胞介素1β通过一种依赖CXCR2的反馈机制抑制胆汁酸诱导的BSEP表达。
PLoS One. 2024 Dec 16;19(12):e0315243. doi: 10.1371/journal.pone.0315243. eCollection 2024.
6
The Selective Endothelin Receptor Antagonist SC0062 in IgA Nephropathy: A Randomized Double-Blind Placebo-Controlled Clinical Trial.选择性内皮素受体拮抗剂SC0062治疗IgA肾病:一项随机双盲安慰剂对照临床试验
J Am Soc Nephrol. 2025 Apr 1;36(4):657-667. doi: 10.1681/ASN.0000000538. Epub 2024 Oct 26.
7
Intraduodenal fecal microbiota transplantation ameliorates gut atrophy and cholestasis in a novel parenteral nutrition piglet model.肠内粪菌移植改善新型肠外营养仔猪模型的肠道萎缩和胆汁淤积。
Am J Physiol Gastrointest Liver Physiol. 2024 Nov 1;327(5):G640-G654. doi: 10.1152/ajpgi.00012.2024. Epub 2024 Aug 20.
8
Safety, pharmacokinetics, and pharmacodynamics in healthy Chinese volunteers treated with SC0062, a highly selective endothelin-A receptor antagonist.在健康的中国志愿者中使用 SC0062(一种高选择性内皮素 A 受体拮抗剂)治疗的安全性、药代动力学和药效学。
Clin Transl Sci. 2024 Mar;17(3):e13750. doi: 10.1111/cts.13750.
9
Chishao () alleviates intra-hepatic cholestasis by modulating NTCP in rats.赤芍通过调节大鼠的钠-牛磺胆酸共转运蛋白(NTCP)减轻肝内胆汁淤积。
Front Pharmacol. 2024 Feb 1;15:1341651. doi: 10.3389/fphar.2024.1341651. eCollection 2024.
10
Cell-based BSEP trans-inhibition: A novel, non-invasive test for diagnosis of antibody-induced BSEP deficiency.基于细胞的BSEP反式抑制:一种用于诊断抗体诱导的BSEP缺乏症的新型非侵入性检测方法。
JHEP Rep. 2023 Feb 1;5(7):100690. doi: 10.1016/j.jhepr.2023.100690. eCollection 2023 Jul.
Clin Res Hepatol Gastroenterol. 2012 Sep;36 Suppl 1:S26-35. doi: 10.1016/S2210-7401(12)70018-9.
4
Novel insight into mechanisms of cholestatic liver injury.对胆汁淤积性肝损伤机制的新认识。
World J Gastroenterol. 2012 Sep 28;18(36):4985-93. doi: 10.3748/wjg.v18.i36.4985.
5
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.减轻药物对人胆汁盐输出泵的抑制作用:通过理化性质调节、计算机建模和结构修饰提供的机会。
Drug Metab Dispos. 2012 Dec;40(12):2332-41. doi: 10.1124/dmd.112.047068. Epub 2012 Sep 7.
6
The bile salt export pump (BSEP) in health and disease.在健康和疾病中的胆汁盐输出泵(BSEP)。
Clin Res Hepatol Gastroenterol. 2012 Dec;36(6):536-53. doi: 10.1016/j.clinre.2012.06.006. Epub 2012 Jul 12.
7
Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2.4-苯丁酸成功治疗进展性家族性肝内胆汁淤积症 2 型患儿的突变特异性伴侣蛋白治疗。
J Hepatol. 2012 Sep;57(3):695-8. doi: 10.1016/j.jhep.2012.04.017. Epub 2012 May 16.
8
AP2 adaptor complex mediates bile salt export pump internalization and modulates its hepatocanalicular expression and transport function.AP2 衔接蛋白复合物介导胆盐输出泵内化,并调节其在胆小管的表达和转运功能。
Hepatology. 2012 Jun;55(6):1889-900. doi: 10.1002/hep.25591.
9
A C-terminal tyrosine-based motif in the bile salt export pump directs clathrin-dependent endocytosis.胆汁盐输出泵的 C 端酪氨酸基基序指导网格蛋白依赖的内吞作用。
Hepatology. 2012 Jun;55(6):1901-11. doi: 10.1002/hep.25523. Epub 2012 Apr 25.
10
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809.通过研究药物 VX-809 纠正体外 F508del-CFTR 蛋白加工缺陷。
Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):18843-8. doi: 10.1073/pnas.1105787108. Epub 2011 Oct 5.